Mas Life Science
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Voglib GM 2mg/500mg/0.3mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Voglib GM 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglib GM 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglib GM 2mg/500mg/0.3mg Tablet.
Voglib GM 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglib GM 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Voglib GM 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Voglib GM 2mg/500mg/0.3mg Tablet contains a combination of Glimepiride, Metformin, and Voglibose, used to treat Type 2 diabetes mellitus (DM). This medication improves blood glucose levels in adults when taken along with a proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas, Metformin works by reducing glucose production in the liver and improving insulin sensitivity, while Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meal) glucose levels.
Common side effects associated with Voglib GM 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infections.
Avoid using Voglib GM 2mg/500mg/0.3mg Tablet if you are allergic to any of the medicine's components or excipients, and also if you have moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol with Voglib GM 2mg/500mg/0.3mg Tablet is not recommended because it might lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Voglib GM 2mg/500mg/0.3mg Tablet may lead to hypoglycemia (low blood sugar levels). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This can occur more often if you miss or delay your meals, drink alcohol, over-exercise, or take other antidiabetic medications concurrently.
Store this medication in its original container and keep it tightly closed, based on the directions provided on the package or label. Do not dispose of unused medication; ensure that it is kept out of reach of pets, children, and other individuals.